SynthesisSocial science & medicine (1982)2009
A meta-analysis of the hepatitis C virus distribution in diverse racial/ethnic drug injector groups.
Synthesis in Social science & medicine (1982), 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
22 citing papers in PubMed, 1 synthesis or guideline pooled it, 39 citations in OpenAlex.
- Meta-analysis of hepatitis C seroconversion in relation to shared syringes and drug preparation equipment.Addiction (Abingdon, England) · 2012Pooled it
- Risk Factors Associated with HCV Among Opioid-Dependent Patients in a Multisite Study.Journal of community health · 2015Trial
- Hepatitis-C multimedia prevention program in poor Hispanic HIV-infected injecting drug users: six months after intervention.Journal of health care for the poor and underserved · 2013Trial
- A simple strategy to identify acute hepatitis C virus infection among newly incarcerated injection drug users.Hepatology (Baltimore, Md.) · 2013Trial
- [Application of anti-HCV and HCV RNA detection in intravenous drug users].Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology · 2021Article
- Psychosocial Factors and the Care Cascade for Hepatitis C Treatment Colocated at a Syringe Service Program.The Journal of infectious diseases · 2020Article
- Treating Opioid Use Disorder and Related Infectious Diseases in the Criminal Justice System.Infectious disease clinics of North America · 2020Review
- Disparities in uptake of direct-acting antiviral therapy for hepatitis C among people who inject drugs in a Canadian setting.Liver international : official journal of the International Association for the Study of the Liver · 2019Article
- 'Hep C's like the common cold': understanding barriers along the HCV care continuum among young people who inject drugs.Drug and alcohol dependence · 2018Article
- Contextual Predictors of Injection Drug Use Among Black Adolescents and Adults in US Metropolitan Areas, 1993-2007.American journal of public health · 2016Article
- Favourable IFNL3 genotypes are associated with spontaneous clearance and are differentially distributed in Aboriginals in Canadian HIV-hepatitis C co-infected individuals.International journal of molecular sciences · 2015Article
- Hepatitis C Infection Among Hispanics in California.Journal of addictive diseases · 2015Article
- Drug use, hepatitis C, and service availability: perspectives of incarcerated rural women.Social work in public health · 2015Article
- Addressing the HIV/AIDS epidemic among Puerto Rican people who inject drugs: the need for a multiregion approach.American journal of public health · 2014Article
- Outlier populations: individual and social network correlates of solvent-using injection drug users.PloS one · 2014Article
- Article
- Perceptions of drug users regarding hepatitis C screening and care: a qualitative study.Harm reduction journal · 2013Article
- Hepatitis C virus-specific immune responses in noninjecting drug users.Journal of viral hepatitis · 2012Article
- Estimates of the population prevalence of injection drug users among hispanic residents of large US metropolitan areas.Journal of urban health : bulletin of the New York Academy of Medicine · 2012Article
- Non-injection drug use and HIV disease progression in the era of combination antiretroviral therapy.Journal of substance abuse treatment · 2011Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors at 6 institutions in 1 country.
Funding
Abstract
Hepatitis C virus (HCV) is mostly transmitted through blood-to-blood contact during injection drug use via shared contaminated syringes/needles or injection paraphernalia. This paper used meta-analytic methods to assess whether HCV prevalence and incidence varied across different racial/ethnic groups of injection drug users (IDUs) sampled internationally. The 29 prevalence and 11 incidence studies identified as part of the HCV Synthesis Project were categorized into subgroups based on similar racial/ethnic comparisons. The effect estimate used was the odds or risk ratio comparing HCV prevalence or incidence rates in racial/ethnic minority groups versus those of majority status. For prevalence studies, the clearest disparity in HCV status was observed in the Canadian and Australian Aboriginal versus White comparison, followed by the US non-White versus White categories. Overall, Hispanic IDUs had greater HCV prevalence, and HCV prevalence in African-Americans was not significantly greater than that of Whites in the US. Aboriginal groups showed higher HCV seroconversion rates when compared to others, and African-Americans had lower seroconversion rates compared to other IDUs in the US. The findings suggest that certain minority groups have elevated HCV rates in comparison to other IDUs, which may be a consequence of stigma, discrimination, different risk behaviors or decreased access to health care, services and preventive education. Future research should seek to explicitly explore and explain racial/ethnic variations in HCV prevalence and incidence, and define the groups more precisely to allow for more accurate detection of possible racial/ethnic differences in HCV rates.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.